Shelter™ DM Matrix + SOC

OTHER2 trials

Sponsors

Sequence LifeScience, Inc.

Conditions

Chronic UlcerDFUDiabetic Foot UlcerDiabetic Foot Ulcer (DFU)Foot Ulcer Due to Type 1 Diabetes MellitusFoot Ulcer Due to Type 2 Diabetes MellitusPressure SorePressure Ulcer (PU)

Phase 4

Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy

RecruitingNCT07086443

Sequence LifeScience, Inc.DFU, Diabetic Foot Ulcer, Diabetic Foot Ulcer (DFU) +4

Start: 2025-07-11End: 2027-07-01Target: 350Updated: 2026-05-19

Study Title: A Multicenter, Prospective, Modified Platform Trial Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Matched Standard of Care Controls in the Management of Nonhealing Pressure Ulcers.

RecruitingNCT07665268

Sequence LifeScience, Inc.Chronic Ulcer, Pressure Sore, Pressure Ulcer of Skin +3

Start: 2026-01-28End: 2028-01-28Target: 2000Updated: 2026-06-24